Fischer Medical Board Approves ₹50 Crore Total Investment in Wholly Owned Subsidiaries
Fischer Medical Ventures Ltd · Outcome · 25 Sept 2026, 4:50 pm
Fischer Medical Board Approves ₹50 Crore Total Investment in Wholly Owned Subsidiaries Fischer Medical Ventures' board approved investments totaling ₹50.00 Cr via rights issues across three material wholly owned subsidiaries on 24th Sep'26. The capital deployment comprises ₹11.50 Cr for 15,603 shares in Time Medical International Ventures (India) at ₹7,370.25 each, ₹12.50 Cr for 1,507 shares in Flynncare Health Innovations at ₹82,943.48 each, and ₹26.00 Cr for 53 shares in Singapore-based FMV Global Innovation Pte. Ltd. at ₹48,83,552.64 each. All transactions are done on an arm's-length cash basis, maintaining 100% ownership across the entities.
Original exchange filing (PDF)
More announcements from Fischer Medical Ventures Ltd
- Financial results for the quarter and half year ended 30th Sept 2026 · 15 Nov 2026
- Outcome of Board Meeting held on 14th Nov 2026 for approval of Q2 financials · 15 Nov 2026
- Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 15 Nov 2026
- The Monitoring Agency Report for the quarter ended 30 September 2026 is enclosed. · 14 Nov 2026
- Fischer Medical Ventures Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the unaudited standalone .... · 14 Nov 2026
- Appointment of Mr Chan Sing En as an Independent Director of FMV Global Innovations Pte.Ltd, Singapore, a Material Wholly Owned Subsidiary Company · 27 Oct 2026
